log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males

Por Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Publicado em 2010

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

Por Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Publicado em 2012

Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B(100) in patients with T2DM

Por Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Publicado em 2013

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids

Por Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Publicado em 2014

The mixed benefit of low lipoprotein(a) in type 2 diabetes

Por Hermans, Michel P., Ahn, Sylvie A., Rousseau, Michel F.
Publicado no Lipids Health Dis (2017)

Non-HDL-cholesterol as valid surrogate to apolipoprotein B(100 )measurement in diabetes: Discriminant Ratio and unbiased equivalence

Por Hermans, Michel P, Sacks, Frank M, Ahn, Sylvie A, Rousseau, Michel F
Publicado em 2011

Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Por Hermans, Michel P., Bouenizabila, Evariste, Amoussou-guenou, Daniel K., Ahn, Sylvie A., Rousseau, Michel F.
Publicado no Cardiovasc Diabetol (2015)

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Por Gruson, Damien, Ferracin, Benjamin, Ahn, Sylvie A., Zierold, Claudia, Blocki, Frank, Hawkins, Douglas M., Bonelli, Fabrizio, Rousseau, Michel F.
Publicado no PLoS One (2015)